Friday, July 30, 2021
HomeNewsCovid-19Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8%...

Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy

Covid-19 Vaccine: Bharat Biotech has released the final phase 3 efficacy data. The company claims it’s made in India vaccine, Covaxin, has shown overall …

source

- Advertisment -

Most Popular

Recent Comments